EUVIMEDEUVIMED entdecken
Leserbrief

Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”

Jiabin Liu, Gwo-Chin Lee

The Journal of Arthroplasty · 2026-07 · 41 (7) · e76-e77

DOI: 10.1016/j.arth.2026.01.076 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Arthroplasty, 2026-07. Verfasst von Jiabin Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care, Hospital for Special Surgery, New York, New York. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Anesthesiology and Critical Care, Hospital for Special Surgery, New York, New York.
  • Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York.

Zitieren

APA

Liu, J., & Lee, G. C. (2026). Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”. The Journal of Arthroplasty, 41(7), e76-e77. https://doi.org/10.1016/j.arth.2026.01.076

Vancouver

Liu J, Lee GC. Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”. The Journal of Arthroplasty. 2026;41(7):e76-e77. doi:10.1016/j.arth.2026.01.076

BibTeX
@article{Liu2026,
  author = {Liu, Jiabin and Lee, Gwo-Chin},
  title = {Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”},
  journal = {The Journal of Arthroplasty},
  year = {2026},
  volume = {41},
  number = {7},
  pages = {e76--e77},
  doi = {10.1016/j.arth.2026.01.076}
}
Kostenlos starten →